Medical Cannabis Tech and Data Company Going Public Soon
April 28, 2021
Robin Lefferts April 28th, 2021 App, Exclusive, News, Top Story If cannabis is to be accepted by the medical community (meaning patients, doctors, researchers, pharma companies, regulators…), there is much to be done in terms of testing the plant, standardizing dosages, and cataloging its effects. After decades of prohibition,... Read more
Microdosing: The Next Revolution in Psychedelics
April 22, 2021
Ryan Allway April 22nd, 2021 App, Exclusive, Psychedelics, Top Story The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress disorder, emerging research suggests that psychedelic substances could have... Read more
AI to Find Needle in Haystack
April 15, 2021
Makenzie Branch April 15th, 2021 App, Exclusive, Psychedelics, Top Story Every year, thousands of molecules are being created, synthesized and tested as drug candidates for a vast number of ailments. MagicMed Industries brings this pharmaceutical development approach to the field of psychedelics to create new therapeutic alternatives for patients... Read more
Ryan Allway April 14th, 2021 App, Exclusive, Psychedelics, Top Story Psychedelics have become one of the most promising classes of drugs in a generation, as well as an exciting new industry for investors. Despite their resurgence among researchers and investors, psychedelics have been used for thousands of years before... Read more
Pre-Public Gage Cannabis Focusing on Regional Dominance
March 25, 2021
Robin Lefferts March 25th, 2021 News, Top Story The United States is governed by a patchwork of state-level cannabis regulations under the umbrella of federal prohibition, making it difficult to build a national business in the industry. Interstate commerce is prohibited, meaning that a national operation would need... Read more
Ryan Allway January 5th, 2021 News, Top Story CBD sales are projected to reach $16.8 billion by 2025, according to Brightfield Group, but the market remains extremely fragmented. With a glut of non-differentiated and low-quality products, regulators are poised to introduce new rules governing the market as consumers increasingly... Read more
MagicMed Targets Massive Market with Pharmaceutical Derivatives Program
December 23, 2020
Ryan Allway December 23rd, 2020 App, Exclusive, Psychedelics, Top Story The psychedelics market is hard to calculate because of the undiscovered therapeutic potential of psychedelic molecules. The scientific community has shown that psychedelics could treat multiple multibillion-dollar markets in the brain and mental health space. MagicMed Industries positions itself... Read more
Innovation Pays Off in Psychedelics
December 18, 2020
Ryan Allway December 18th, 2020 App, Exclusive, Psychedelics, Top Story There has been significant interest in the psychedelic space and of the promise psychedelic molecules show in treating mental health conditions. Mental illness is a ubiquitous human experience and an insufficiently addressed medical necessity. Psychedelics offer an alternative to... Read more
Why Focus on Cannabis & Mushroom Extracts?
CBD November 25, 2020
Ryan Allway November 25th, 2020 App, Exclusive, News, Top Story Cannabis extracts are poised to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. At the same time, the functional mushroom market is forecast to reach $34.3 billion... Read more
How to Invest in the Rise of Cannabis-Infused Beverages
November 18, 2020
Ryan Allway November 18th, 2020 App, Exclusive, News, Top Story The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry... Read more
